Table of Contents

Articles

• You have access

  Structural Evaluation of the Agonistic Action of a Vitamin D Analog with Two Side Chains Binding to the Nuclear Vitamin D Receptor

  Sami Väisänen, Mikael Peräkylä, Jouni I. Kärkkäinen, Milan R. Uskokovic and Carsten Carlberg

  Molecular Pharmacology June 2003, 63 (6) 1230-1237; DOI: https://doi.org/10.1124/mol.63.6.1230
• You have access

  Hypertonicity Inhibits Lipopolysaccharide-Induced Nitric Oxide Synthase Expression in Smooth Muscle Cells by Inhibiting Nuclear Factor κB

  Sandeep C. Pingle, Joseph F. Sanchez, Daniel M. Hallam, Andrea L. Williamson, Sanjay B. Maggirwar and Vickram Ramkumar

  Molecular Pharmacology June 2003, 63 (6) 1238-1247; DOI: https://doi.org/10.1124/mol.63.6.1238
• You have access

  Non-Nuclear Localized Human NOSII Enhances the Bioactivation and Toxicity of Tirapazamine (SR4233) in Vitro

  Edwin C. Chinje, Rachel L. Cowen, Jian Feng, Sanjeev P. Sharma, Natasha S. Wind, Adrian L. Harris and Ian J. Stratford

  Molecular Pharmacology June 2003, 63 (6) 1248-1255; DOI: https://doi.org/10.1124/mol.63.6.1248
• You have access

  The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints

  Robert Fredriksson, Malin C. Lagerström, Lars-Gustav Lundin and Helgi B. Schiöth

  Molecular Pharmacology June 2003, 63 (6) 1256-1272; DOI: https://doi.org/10.1124/mol.63.6.1256
• You have access

  Diazonamide A and a Synthetic Structural Analog: Disruptive Effects on Mitosis and Cellular Microtubules and Analysis of Their Interactions with Tubulin

  Zobeida Cruz-Monserrate, Hélène C. Vervoort, Ruoli Bai, David J. Newman, Stephen B. Howell, Gerrit Los, Jeffrey T. Mullaney, Michael D. Williams, George R. Pettit, William Fenical and Ernest Hamel

  Molecular Pharmacology June 2003, 63 (6) 1273-1280; DOI: https://doi.org/10.1124/mol.63.6.1273
• You have access

  Decrease in Survival Threshold of Quiescent Colon Carcinoma Cells in the Presence of a Small Molecule Integrin Antagonist

  Mike F. Burbridge, Virginie Venot, Patrick J. Casara, Françoise Perron-Sierra, John A. Hickman and Gordon C. Tucker

  Molecular Pharmacology June 2003, 63 (6) 1281-1288; DOI: https://doi.org/10.1124/mol.63.6.1281
• You have access

  Inhibition of Human Insulin Gene Transcription by the Immunosuppressive Drugs Cyclosporin A and Tacrolimus in Primary, Mature Islets of Transgenic Mice

  Elke Oetjen, Diana Baun, Stephan Beimesche, Doris Krause, Irmgard Cierny, Roland Blume, Corinna Dickel, Simone Wehner and Willhart Knepel

  Molecular Pharmacology June 2003, 63 (6) 1289-1295; DOI: https://doi.org/10.1124/mol.63.6.1289
• You have access

  Thyroid Hormone Induction of the Adrenoleukodystrophy-Related Gene (ABCD2)

  Stéphane Fourcade, Stéphane Savary, Catherine Gondcaille, Johannes Berger, Angela Netik, Françoise Cadepond, Martine El Etr, Brunhilde Molzer and Maurice Bugaut

  Molecular Pharmacology June 2003, 63 (6) 1296-1303; DOI: https://doi.org/10.1124/mol.63.6.1296
• You have access

  2-Aminoethoxydiphenyl Borane Activates a Novel Calcium-Permeable Cation Channel

  Franz-Josef Braun, Omar Aziz and James W. Putney

  Molecular Pharmacology June 2003, 63 (6) 1304-1311; DOI: https://doi.org/10.1124/mol.63.6.1304
• You have access

  Agonist Actions of “β-Blockers” Provide Evidence for Two Agonist Activation Sites or Conformations of the Human β₁-Adrenoceptor

  Jillian G. Baker, Ian P. Hall and Stephen J. Hill

  Molecular Pharmacology June 2003, 63 (6) 1312-1321; DOI: https://doi.org/10.1124/mol.63.6.1312
• You have access

  Enhancement of Long-Term Potentiation by a Potent Nitric Oxide-Guanylyl Cyclase Activator, 3-(5-Hydroxymethyl-2-furyl)-1-benzyl-indazole

  Wei-Lin Chien, Keng-Chen Liang, Che-Ming Teng, Sheng-Chu Kuo, Fang-Yu Lee and Wen-Mei Fu

  Molecular Pharmacology June 2003, 63 (6) 1322-1328; DOI: https://doi.org/10.1124/mol.63.6.1322
• You have access

  Developmental Expression of Heteromeric Nicotinic Receptor Subtypes in Chick Retina

  S. Vailati, M. Moretti, R. Longhi, G. E. Rovati, F. Clementi and C. Gotti

  Molecular Pharmacology June 2003, 63 (6) 1329-1337; DOI: https://doi.org/10.1124/mol.63.6.1329
• You have access

  Developmental Changes in β₂-Adrenergic Receptor Signaling in Ventricular Myocytes: the Role of Gi proteins and Caveolae Microdomains

  Vitalyi O. Rybin, Elena Pak, Sasha Alcott and Susan F. Steinberg

  Molecular Pharmacology June 2003, 63 (6) 1338-1348; DOI: https://doi.org/10.1124/mol.63.6.1338
• You have access

  Thiol-Modifying Phenylarsine Oxide Inhibits Guanine Nucleotide Binding of Rho but Not of Rac GTPases

  Ralf Gerhard, Harald John, Klaus Aktories and Ingo Just

  Molecular Pharmacology June 2003, 63 (6) 1349-1355; DOI: https://doi.org/10.1124/mol.63.6.1349
• You have access

  Characterization of a Ca²⁺ Response to Both UTP and ATP at Human P2Y₁₁ Receptors: Evidence for Agonist-Specific Signaling

  Pamela J. White, Tania E. Webb and Michael R. Boarder

  Molecular Pharmacology June 2003, 63 (6) 1356-1363; DOI: https://doi.org/10.1124/mol.63.6.1356
• You have access

  [³H]Sildenafil Binding to Phosphodiesterase-5 Is Specific, Kinetically Heterogeneous, and Stimulated by cGMP

  Jackie D. Corbin, Mitsi A. Blount, James L. Weeks, Alfreda Beasley, Karl P. Kuhn, Yew S. J. Ho, Layla F. Saidi, James H. Hurley, Jun Kotera and Sharron H. Francis

  Molecular Pharmacology June 2003, 63 (6) 1364-1372; DOI: https://doi.org/10.1124/mol.63.6.1364
• You have access

  Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG2 Cancer Cells

  Maen Abdelrahim, Roger Smith and Stephen Safe

  Molecular Pharmacology June 2003, 63 (6) 1373-1381; DOI: https://doi.org/10.1124/mol.63.6.1373
• You have access

  DNA Sequence Specificity for Topoisomerase II Poisoning by the Quinoxaline Anticancer Drugs XK469 and CQS

  Hanlin Gao, Edith F. Yamasaki, Kenneth K. Chan, Linus L. Shen and Robert M. Snapka

  Molecular Pharmacology June 2003, 63 (6) 1382-1388; DOI: https://doi.org/10.1124/mol.63.6.1382
• You have access

  Closure of Gap Junction Channels by Arylaminobenzoates

  Miduturu Srinivas and David C. Spray

  Molecular Pharmacology June 2003, 63 (6) 1389-1397; DOI: https://doi.org/10.1124/mol.63.6.1389
• You have access

  Point Mutations at L1280 in Na_v1.4 Channel D3-S6 Modulate Binding Affinity and Stereoselectivity of Bupivacaine Enantiomers

  Carla Nau, Sho-Ya Wang and Ging Kuo Wang

  Molecular Pharmacology June 2003, 63 (6) 1398-1406; DOI: https://doi.org/10.1124/mol.63.6.1398
• You have access

  Pharmacological and Biophysical Properties of the Human P2X₅ Receptor

  Xuenong Bo, Lin-Hua Jiang, Heather L. Wilson, Miran Kim, Geoffrey Burnstock, Annmarie Surprenant and R. Alan North

  Molecular Pharmacology June 2003, 63 (6) 1407-1416; DOI: https://doi.org/10.1124/mol.63.6.1407
• You have access

  Local Anesthetic Block of Kv Channels: Role of the S6 Helix and the S5-S6 Linker for Bupivacaine Action

  Johanna Nilsson, Michael Madeja and Peter Århem

  Molecular Pharmacology June 2003, 63 (6) 1417-1429; DOI: https://doi.org/10.1124/mol.63.6.1417
• You have access

  Extra- and Intracellular Sphingosylphosphorylcholine Promote Spontaneous Transmitter Release from Frog Motor Nerve Endings

  Eugen Brailoiu and Nae J. Dun

  Molecular Pharmacology June 2003, 63 (6) 1430-1436; DOI: https://doi.org/10.1124/mol.63.6.1430
• You have access

  A Key Role for Caspase-2 and Caspase-3 in the Apoptosis Induced by 2-Chloro-2′-deoxy-adenosine (Cladribine) and 2-Chloro-adenosine in Human Astrocytoma Cells

  Stefania Ceruti, Elena Beltrami, Paola Matarrese, Alessia Mazzola, Flaminio Cattabeni, Walter Malorni and Maria P. Abbracchio

  Molecular Pharmacology June 2003, 63 (6) 1437-1447; DOI: https://doi.org/10.1124/mol.63.6.1437